August 20, 2021 Comments Off on New patent for Astrazeneca Ab drug BYDUREON Posted in: Patent Added Annual Drug Patent Expirations for BYDUREON Bydureon is a drug marketed by Astrazeneca Ab and is included in two NDAs. It is available from one supplier. There are twenty-three patents…
The post New patent for Astrazeneca Ab drug BYDUREON appeared firs…
August 19, 2021 Comments Off on New patent for Qed Therap drug TRUSELTIQ Posted in: Patent Added Annual Drug Patent Expirations for TRUSELTIQ Truseltiq is a drug marketed by Qed Therap and is included in one NDA. There are three patents protecting this drug. This drug has…
The post New patent for Qed Therap drug TRUSELTIQ appeared first on DrugPat…
